메뉴 건너뛰기




Volumn 18, Issue 11, 2017, Pages

The C-C chemokines CCL17 and CCL22 and their receptor CCR4 in CNS autoimmunity

Author keywords

CCL17; CCL22; CCR4; Chemokines; Cns autoimmunity; Dendritic cells; Experimental autoimmune encephalomyelitis; Migration; Multiple sclerosis; Neuroinflammation

Indexed keywords

BETA CHEMOKINE; CD40 ANTIGEN; CHEMOKINE; CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CCR4 ANTAGONIST; GAMMA INTERFERON; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 4; LIGAND; LYMPHOTACTIN; MACROPHAGE DERIVED CHEMOKINE; MOGAMULIZUMAB; THYMUS AND ACTIVATION REGULATED CHEMOKINE; TUMOR NECROSIS FACTOR; UTOMILUMAB;

EID: 85033607396     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms18112306     Document Type: Review
Times cited : (102)

References (117)
  • 1
    • 54149084585 scopus 로고    scopus 로고
    • Multiple sclerosis
    • Compston, A.; Coles, A. Multiple sclerosis. Lancet 2008, 372, 1502-1517.
    • (2008) Lancet , vol.372 , pp. 1502-1517
    • Compston, A.1    Coles, A.2
  • 3
    • 84930930111 scopus 로고    scopus 로고
    • Pharmacological approaches to delaying disability progression in patients with multiple sclerosis
    • Wiendl, H.; Meuth, S.G. Pharmacological approaches to delaying disability progression in patients with multiple sclerosis. Drugs 2015, 75, 947-977.
    • (2015) Drugs , vol.75 , pp. 947-977
    • Wiendl, H.1    Meuth, S.G.2
  • 4
    • 70249106760 scopus 로고    scopus 로고
    • EAE: An immunologist’s magic eye
    • Krishnamoorthy, G.; Wekerle, H. EAE: An immunologist’s magic eye. Eur. J. Immunol. 2009, 39, 2031-2035.
    • (2009) Eur. J. Immunol , vol.39 , pp. 2031-2035
    • Krishnamoorthy, G.1    Wekerle, H.2
  • 5
    • 84991772094 scopus 로고    scopus 로고
    • Multiple sclerosis: Experimental models and reality
    • Lassmann, H.; Bradl, M. Multiple sclerosis: Experimental models and reality. Acta Neuropathol. 2017, 133, 223-244.
    • (2017) Acta Neuropathol , vol.133 , pp. 223-244
    • Lassmann, H.1    Bradl, M.2
  • 6
    • 0036219003 scopus 로고    scopus 로고
    • T cell response in experimental autoimmune encephalomyelitis (EAE): Role of self and cross-reactive antigens in shaping, tuning, and regulating the autopathogenic T cell repertoire
    • Kuchroo, V.K.; Anderson, A.C.; Waldner, H.; Munder, M.; Bettelli, E.; Nicholson, L.B. T cell response in experimental autoimmune encephalomyelitis (EAE): Role of self and cross-reactive antigens in shaping, tuning, and regulating the autopathogenic T cell repertoire. Annu. Rev. Immunol. 2002, 20, 101-123.
    • (2002) Annu. Rev. Immunol , vol.20 , pp. 101-123
    • Kuchroo, V.K.1    Anderson, A.C.2    Waldner, H.3    Munder, M.4    Bettelli, E.5    Nicholson, L.B.6
  • 7
    • 81755184012 scopus 로고    scopus 로고
    • Cytokines and effector T cell subsets causing autoimmune CNS disease
    • Petermann, F.; Korn, T. Cytokines and effector T cell subsets causing autoimmune CNS disease. FEBS Lett. 2011, 585, 3747-3757.
    • (2011) FEBS Lett , vol.585 , pp. 3747-3757
    • Petermann, F.1    Korn, T.2
  • 8
    • 84933512276 scopus 로고    scopus 로고
    • T cell mediated pathogenesis in EAE: Molecular mechanisms
    • Kurschus, F.C. T cell mediated pathogenesis in EAE: Molecular mechanisms. Biomed. J. 2015, 38, 183-193.
    • (2015) Biomed. J , vol.38 , pp. 183-193
    • Kurschus, F.C.1
  • 9
    • 84864124859 scopus 로고    scopus 로고
    • IL-12 family cytokines: Immunological playmakers
    • Vignali, D.A.; Kuchroo, V.K. IL-12 family cytokines: Immunological playmakers. Nat. Immunol. 2012, 13, 722-728.
    • (2012) Nat. Immunol , vol.13 , pp. 722-728
    • Vignali, D.A.1    Kuchroo, V.K.2
  • 10
    • 35848951169 scopus 로고    scopus 로고
    • Autoaggressive effector T cells in the course of experimental autoimmune encephalomyelitis visualized in the light of two-photon microscopy
    • Flugel, A.; Odoardi, F.; Nosov, M.; Kawakami, N. Autoaggressive effector T cells in the course of experimental autoimmune encephalomyelitis visualized in the light of two-photon microscopy. J. Neuroimmunol. 2007, 191, 86-97.
    • (2007) J. Neuroimmunol , vol.191 , pp. 86-97
    • Flugel, A.1    Odoardi, F.2    Nosov, M.3    Kawakami, N.4
  • 11
    • 84896902938 scopus 로고    scopus 로고
    • Chemokines and chemokine receptors: Positioning cells for host defense and immunity
    • Griffith, J.W.; Sokol, C.L.; Luster, A.D. Chemokines and chemokine receptors: Positioning cells for host defense and immunity. Annu. Rev. Immunol. 2014, 32, 659-702.
    • (2014) Annu. Rev. Immunol , vol.32 , pp. 659-702
    • Griffith, J.W.1    Sokol, C.L.2    Luster, A.D.3
  • 12
    • 84861426163 scopus 로고    scopus 로고
    • The chemokine superfamily revisited
    • Zlotnik, A.; Yoshie, O. The chemokine superfamily revisited. Immunity 2012, 36, 705-716.
    • (2012) Immunity , vol.36 , pp. 705-716
    • Zlotnik, A.1    Yoshie, O.2
  • 13
    • 34547281274 scopus 로고    scopus 로고
    • Chemokines and chemokine receptors: Multipurpose players in neuroinflammation
    • Ransohoff, R.M.; Liu, L.; Cardona, A.E. Chemokines and chemokine receptors: Multipurpose players in neuroinflammation. Int. Rev. Neurobiol. 2007, 82, 187-204.
    • (2007) Int. Rev. Neurobiol , vol.82 , pp. 187-204
    • Ransohoff, R.M.1    Liu, L.2    Cardona, A.E.3
  • 14
    • 50049123401 scopus 로고    scopus 로고
    • Chemokines and leukocyte traffic
    • Sallusto, F.; Baggiolini, M. Chemokines and leukocyte traffic. Nat. Immunol. 2008, 9, 949-952.
    • (2008) Nat. Immunol , vol.9 , pp. 949-952
    • Sallusto, F.1    Baggiolini, M.2
  • 15
    • 0034083091 scopus 로고    scopus 로고
    • The role of chemokine receptors in primary, effector, and memory immune responses
    • Sallusto, F.; Mackay, C.R.; Lanzavecchia, A. The role of chemokine receptors in primary, effector, and memory immune responses. Annu. Rev. Immunol. 2000, 18, 593-620.
    • (2000) Annu. Rev. Immunol , vol.18 , pp. 593-620
    • Sallusto, F.1    Mackay, C.R.2    Lanzavecchia, A.3
  • 16
    • 34248339649 scopus 로고    scopus 로고
    • Chemokines and chemokine receptors in the brain: Implication in neuroendocrine regulation
    • Callewaere, C.; Banisadr, G.; Rostene, W.; Parsadaniantz, S.M. Chemokines and chemokine receptors in the brain: Implication in neuroendocrine regulation. J. Mol. Endocrinol. 2007, 38, 355-363.
    • (2007) J. Mol. Endocrinol , vol.38 , pp. 355-363
    • Callewaere, C.1    Banisadr, G.2    Rostene, W.3    Parsadaniantz, S.M.4
  • 17
    • 70449525704 scopus 로고    scopus 로고
    • Chemokines and chemokine receptors: Standing at the crossroads of immunobiology and neurobiology
    • Ransohoff, R.M. Chemokines and chemokine receptors: Standing at the crossroads of immunobiology and neurobiology. Immunity 2009, 31, 711-721.
    • (2009) Immunity , vol.31 , pp. 711-721
    • Ransohoff, R.M.1
  • 19
    • 84941804524 scopus 로고    scopus 로고
    • Fractalkine in the nervous system: Neuroprotective or neurotoxic molecule?
    • Lauro, C.; Catalano, M.; Trettel, F.; Limatola, C. Fractalkine in the nervous system: Neuroprotective or neurotoxic molecule? Ann. N. Y. Acad. Sci. 2015, 1351, 141-148.
    • (2015) Ann. N. Y. Acad. Sci , vol.1351 , pp. 141-148
    • Lauro, C.1    Catalano, M.2    Trettel, F.3    Limatola, C.4
  • 20
    • 84977519286 scopus 로고    scopus 로고
    • Atypical Chemokine Receptors and Their Roles in the Resolution of the Inflammatory Response
    • Bonecchi, R.; Graham, G.J. Atypical Chemokine Receptors and Their Roles in the Resolution of the Inflammatory Response. Front. Immunol. 2016, 7, 224.
    • (2016) Front. Immunol , vol.7 , pp. 224
    • Bonecchi, R.1    Graham, G.J.2
  • 21
    • 79952105330 scopus 로고    scopus 로고
    • Chemokine oligomerization and interactions with receptors and glycosaminoglycans: The role of structural dynamics in function
    • Salanga, C.L.; Handel, T.M. Chemokine oligomerization and interactions with receptors and glycosaminoglycans: The role of structural dynamics in function. Exp. Cell Res. 2011, 317, 590-601.
    • (2011) Exp. Cell Res , vol.317 , pp. 590-601
    • Salanga, C.L.1    Handel, T.M.2
  • 22
    • 54849415924 scopus 로고    scopus 로고
    • Fluorescence resonance energy transfer imaging reveals that chemokine-binding modulates heterodimers of CXCR4 and CCR5 receptors
    • Isik, N.; Hereld, D.; Jin, T. Fluorescence resonance energy transfer imaging reveals that chemokine-binding modulates heterodimers of CXCR4 and CCR5 receptors. PLoS ONE 2008, 3, e3424.
    • (2008) PLoS ONE , vol.3
    • Isik, N.1    Hereld, D.2    Jin, T.3
  • 24
    • 85012912282 scopus 로고    scopus 로고
    • Differential structural remodelling of heparan sulfate by chemokines: The role of chemokine oligomerization
    • Dyer, D.P.; Migliorini, E.; Salanga, C.L.; Thakar, D.; Handel, T.M.; Richter, R.P. Differential structural remodelling of heparan sulfate by chemokines: The role of chemokine oligomerization. Open Biol. 2017, 7.
    • (2017) Open Biol , vol.7
    • Dyer, D.P.1    Migliorini, E.2    Salanga, C.L.3    Thakar, D.4    Handel, T.M.5    Richter, R.P.6
  • 25
    • 84959429965 scopus 로고    scopus 로고
    • The dependence of chemokine-glycosaminoglycan interactions on chemokine oligomerization
    • Dyer, D.P.; Salanga, C.L.; Volkman, B.F.; Kawamura, T.; Handel, T.M. The dependence of chemokine-glycosaminoglycan interactions on chemokine oligomerization. Glycobiology 2016, 26, 312-326.
    • (2016) Glycobiology , vol.26 , pp. 312-326
    • Dyer, D.P.1    Salanga, C.L.2    Volkman, B.F.3    Kawamura, T.4    Handel, T.M.5
  • 26
    • 0029102101 scopus 로고
    • Molecular cloning and functional expression of a novel CC chemokine receptor cDNA from a human basophilic cell line
    • Power, C.A.; Meyer, A.; Nemeth, K.; Bacon, K.B.; Hoogewerf, A.J.; Proudfoot, A.E.; Wells, T.N. Molecular cloning and functional expression of a novel CC chemokine receptor cDNA from a human basophilic cell line. J. Biol. Chem. 1995, 270, 19495-19500.
    • (1995) J. Biol. Chem , vol.270 , pp. 19495-19500
    • Power, C.A.1    Meyer, A.2    Nemeth, K.3    Bacon, K.B.4    Hoogewerf, A.J.5    Proudfoot, A.E.6    Wells, T.N.7
  • 27
    • 0030021091 scopus 로고    scopus 로고
    • Molecular cloning of murine CC CKR-4 and high affinity binding of chemokines to murine and human CC CKR-4
    • Hoogewerf, A.; Black, D.; Proudfoot, A.E.; Wells, T.N.; Power, C.A. Molecular cloning of murine CC CKR-4 and high affinity binding of chemokines to murine and human CC CKR-4. Biochem. Biophys. Res. Commun. 1996, 218, 337-343.
    • (1996) Biochem. Biophys. Res. Commun , vol.218 , pp. 337-343
    • Hoogewerf, A.1    Black, D.2    Proudfoot, A.E.3    Wells, T.N.4    Power, C.A.5
  • 28
    • 84922475661 scopus 로고    scopus 로고
    • CCR4 and its ligands: From bench to bedside
    • Yoshie, O.; Matsushima, K. CCR4 and its ligands: From bench to bedside. Int. Immunol. 2015, 27, 11-20.
    • (2015) Int. Immunol , vol.27 , pp. 11-20
    • Yoshie, O.1    Matsushima, K.2
  • 29
    • 0032533795 scopus 로고    scopus 로고
    • Selective up-regulation of chemokine receptors CCR4 and CCR8 upon activation of polarized human type 2 Th cells
    • D’Ambrosio, D.; Iellem, A.; Bonecchi, R.; Mazzeo, D.; Sozzani, S.; Mantovani, A.; Sinigaglia, F. Selective up-regulation of chemokine receptors CCR4 and CCR8 upon activation of polarized human type 2 Th cells. J. Immunol. 1998, 161, 5111-5115.
    • (1998) J. Immunol , vol.161 , pp. 5111-5115
    • D’Ambrosio, D.1    Iellem, A.2    Bonecchi, R.3    Mazzeo, D.4    Sozzani, S.5    Mantovani, A.6    Sinigaglia, F.7
  • 30
    • 0033140106 scopus 로고    scopus 로고
    • The role of chemokines and chemokine receptors in T cell priming and Th1/Th2-mediated responses
    • Sallusto, F. The role of chemokines and chemokine receptors in T cell priming and Th1/Th2-mediated responses. Haematologica 1999, 84, 28-31.
    • (1999) Haematologica , vol.84 , pp. 28-31
    • Sallusto, F.1
  • 33
    • 40449111457 scopus 로고    scopus 로고
    • Human Th17 cells share major trafficking receptors with both polarized effector T cells and FOXP3+ regulatory T cells
    • Lim, H.W.; Lee, J.; Hillsamer, P.; Kim, C.H. Human Th17 cells share major trafficking receptors with both polarized effector T cells and FOXP3+ regulatory T cells. J. Immunol. 2008, 180, 122-129.
    • (2008) J. Immunol , vol.180 , pp. 122-129
    • Lim, H.W.1    Lee, J.2    Hillsamer, P.3    Kim, C.H.4
  • 34
    • 33751569559 scopus 로고    scopus 로고
    • Evidence for NK cell subsets based on chemokine receptor expression
    • Berahovich, R.D.; Lai, N.L.; Wei, Z.; Lanier, L.L.; Schall, T.J. Evidence for NK cell subsets based on chemokine receptor expression. J. Immunol. 2006, 177, 7833-7840.
    • (2006) J. Immunol , vol.177 , pp. 7833-7840
    • Berahovich, R.D.1    Lai, N.L.2    Wei, Z.3    Lanier, L.L.4    Schall, T.J.5
  • 36
    • 0036709217 scopus 로고    scopus 로고
    • Induction of macrophage-derived chemokine/CCL22 expression in experimental autoimmune encephalomyelitis and cultured microglia: Implications for disease regulation
    • Columba-Cabezas, S.; Serafini, B.; Ambrosini, E.; Sanchez, M.; Penna, G.; Adorini, L.; Aloisi, F. Induction of macrophage-derived chemokine/CCL22 expression in experimental autoimmune encephalomyelitis and cultured microglia: Implications for disease regulation. J. Neuroimmunol. 2002, 130, 10-21.
    • (2002) J. Neuroimmunol , vol.130 , pp. 10-21
    • Columba-Cabezas, S.1    Serafini, B.2    Ambrosini, E.3    Sanchez, M.4    Penna, G.5    Adorini, L.6    Aloisi, F.7
  • 38
    • 0036247211 scopus 로고    scopus 로고
    • Cytokines and chemoattractants in allergic inflammation
    • Romagnani, S. Cytokines and chemoattractants in allergic inflammation. Mol. Immunol. 2002, 38, 881-885.
    • (2002) Mol. Immunol , vol.38 , pp. 881-885
    • Romagnani, S.1
  • 39
    • 79959415857 scopus 로고    scopus 로고
    • Chemokine receptor requirements for epidermal T-cell trafficking
    • Tubo, N.J.; McLachlan, J.B.; Campbell, J.J. Chemokine receptor requirements for epidermal T-cell trafficking. Am. J. Pathol. 2011, 178, 2496-2503.
    • (2011) Am. J. Pathol , vol.178 , pp. 2496-2503
    • Tubo, N.J.1    McLachlan, J.B.2    Campbell, J.J.3
  • 42
    • 33947254437 scopus 로고    scopus 로고
    • Cutting Edge: Chemokine receptor CCR4 is necessary for antigen-driven cutaneous accumulation of CD4 T cells under physiological conditions
    • Campbell, J.J.; O’Connell, D.J.; Wurbel, M.A. Cutting Edge: Chemokine receptor CCR4 is necessary for antigen-driven cutaneous accumulation of CD4 T cells under physiological conditions. J. Immunol. 2007, 178, 3358-3362.
    • (2007) J. Immunol , vol.178 , pp. 3358-3362
    • Campbell, J.J.1    O’Connell, D.J.2    Wurbel, M.A.3
  • 43
    • 33751568123 scopus 로고    scopus 로고
    • CCR4 is a key modulator of innate immune responses
    • Ness, T.L.; Ewing, J.L.; Hogaboam, C.M.; Kunkel, S.L. CCR4 is a key modulator of innate immune responses. J. Immunol. 2006, 177, 7531-7539.
    • (2006) J. Immunol , vol.177 , pp. 7531-7539
    • Ness, T.L.1    Ewing, J.L.2    Hogaboam, C.M.3    Kunkel, S.L.4
  • 45
    • 0030987778 scopus 로고    scopus 로고
    • The T cell-directed CC chemokine TARC is a highly specific biological ligand for CC chemokine receptor 4
    • Imai, T.; Baba, M.; Nishimura, M.; Kakizaki, M.; Takagi, S.; Yoshie, O. The T cell-directed CC chemokine TARC is a highly specific biological ligand for CC chemokine receptor 4. J. Biol. Chem. 1997, 272, 15036-15042.
    • (1997) J. Biol. Chem , vol.272 , pp. 15036-15042
    • Imai, T.1    Baba, M.2    Nishimura, M.3    Kakizaki, M.4    Takagi, S.5    Yoshie, O.6
  • 46
    • 0342316467 scopus 로고    scopus 로고
    • The murine beta-chemokine TARC is expressed by subsets of dendritic cells and attracts primed CD4+ T cells
    • Lieberam, I.; Forster, I. The murine beta-chemokine TARC is expressed by subsets of dendritic cells and attracts primed CD4+ T cells. Eur. J. Immunol. 1999, 29, 2684-2694.
    • (1999) Eur. J. Immunol , vol.29 , pp. 2684-2694
    • Lieberam, I.1    Forster, I.2
  • 47
    • 0037416171 scopus 로고    scopus 로고
    • Compartmentalized production of CCL17 in vivo: Strong inducibility in peripheral dendritic cells contrasts selective absence from the spleen
    • Alferink, J.; Lieberam, I.; Reindl, W.; Behrens, A.; Weiss, S.; Huser, N.; Gerauer, K.; Ross, R.; Reske-Kunz, A.B.; Ahmad-Nejad, P.; et al. Compartmentalized production of CCL17 in vivo: Strong inducibility in peripheral dendritic cells contrasts selective absence from the spleen. J. Exp. Med. 2003, 197, 585-599.
    • (2003) J. Exp. Med , vol.197 , pp. 585-599
    • Alferink, J.1    Lieberam, I.2    Reindl, W.3    Behrens, A.4    Weiss, S.5    Huser, N.6    Gerauer, K.7    Ross, R.8    Reske-Kunz, A.B.9    Ahmad-Nejad, P.10
  • 49
    • 84856231283 scopus 로고    scopus 로고
    • CCL17 promotes intestinal inflammation in mice and counteracts regulatory T cell-mediated protection from colitis
    • Heiseke, A.F.; Faul, A.C.; Lehr, H.A.; Forster, I.; Schmid, R.M.; Krug, A.B.; Reindl, W. CCL17 promotes intestinal inflammation in mice and counteracts regulatory T cell-mediated protection from colitis. Gastroenterology 2012, 142, 335-345.
    • (2012) Gastroenterology , vol.142 , pp. 335-345
    • Heiseke, A.F.1    Faul, A.C.2    Lehr, H.A.3    Forster, I.4    Schmid, R.M.5    Krug, A.B.6    Reindl, W.7
  • 51
    • 0025735629 scopus 로고
    • The dendritic cell system and its role in immunogenicity
    • Steinman, R.M. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 1991, 9, 271-296.
    • (1991) Annu. Rev. Immunol , vol.9 , pp. 271-296
    • Steinman, R.M.1
  • 52
    • 0036518287 scopus 로고    scopus 로고
    • Mouse and human dendritic cell subtypes
    • Shortman, K.; Liu, Y.J. Mouse and human dendritic cell subtypes. Nat. Rev. Immunol. 2002, 2, 151-161.
    • (2002) Nat. Rev. Immunol , vol.2 , pp. 151-161
    • Shortman, K.1    Liu, Y.J.2
  • 56
    • 0031849219 scopus 로고    scopus 로고
    • Human chemokines fractalkine (SCYD1), MDC (SCYA22) and TARC (SCYA17) are clustered on chromosome 16q13
    • Nomiyama, H.; Imai, T.; Kusuda, J.; Miura, R.; Callen, D.F.; Yoshie, O. Human chemokines fractalkine (SCYD1), MDC (SCYA22) and TARC (SCYA17) are clustered on chromosome 16q13. Cytogenet. Cell Genet. 1998, 81, 10-11.
    • (1998) Cytogenet. Cell Genet , vol.81 , pp. 10-11
    • Nomiyama, H.1    Imai, T.2    Kusuda, J.3    Miura, R.4    Callen, D.F.5    Yoshie, O.6
  • 57
    • 67650485985 scopus 로고    scopus 로고
    • Alternative activation of macrophages: An immunologic functional perspective
    • Martinez, F.O.; Helming, L.; Gordon, S. Alternative activation of macrophages: An immunologic functional perspective. Annu. Rev. Immunol. 2009, 27, 451-483.
    • (2009) Annu. Rev. Immunol , vol.27 , pp. 451-483
    • Martinez, F.O.1    Helming, L.2    Gordon, S.3
  • 58
    • 0035500756 scopus 로고    scopus 로고
    • Cutting edge: CCR4 mediates antigen-primed T cell binding to activated dendritic cells
    • Wu, M.; Fang, H.; Hwang, S.T. Cutting edge: CCR4 mediates antigen-primed T cell binding to activated dendritic cells. J. Immunol. 2001, 167, 4791-4795.
    • (2001) J. Immunol , vol.167 , pp. 4791-4795
    • Wu, M.1    Fang, H.2    Hwang, S.T.3
  • 59
    • 0036032065 scopus 로고    scopus 로고
    • Regulation of macrophage-derived chemokine (MDC, CCL22) production
    • Yamashita, U.; Kuroda, E. Regulation of macrophage-derived chemokine (MDC, CCL22) production. Crit. Rev. Immunol. 2002, 22, 105-114.
    • (2002) Crit. Rev. Immunol , vol.22 , pp. 105-114
    • Yamashita, U.1    Kuroda, E.2
  • 62
    • 0037381799 scopus 로고    scopus 로고
    • Both IL-4 and IL-13 inhibit the TNF-alpha and IFN-gamma enhanced MDC production in a human keratinocyte cell line, HaCaT cells
    • Xiao, T.; Kagami, S.; Saeki, H.; Sugaya, M.; Kakinuma, T.; Fujita, H.; Yano, S.; Mitsui, H.; Torii, H.; Komine, M.; et al. Both IL-4 and IL-13 inhibit the TNF-alpha and IFN-gamma enhanced MDC production in a human keratinocyte cell line, HaCaT cells. J. Dermatol. Sci. 2003, 31, 111-117.
    • (2003) J. Dermatol. Sci , vol.31 , pp. 111-117
    • Xiao, T.1    Kagami, S.2    Saeki, H.3    Sugaya, M.4    Kakinuma, T.5    Fujita, H.6    Yano, S.7    Mitsui, H.8    Torii, H.9    Komine, M.10
  • 63
    • 84861668636 scopus 로고    scopus 로고
    • Dendritic cells and alveolar macrophages mediate IL-13-induced airway inflammation and chemokine production
    • Crapster-Pregont, M.; Yeo, J.; Sanchez, R.L.; Kuperman, D.A. Dendritic cells and alveolar macrophages mediate IL-13-induced airway inflammation and chemokine production. J. Allergy Clin. Immunol. 2012, 129, 1621-1627.
    • (2012) J. Allergy Clin. Immunol , vol.129 , pp. 1621-1627
    • Crapster-Pregont, M.1    Yeo, J.2    Sanchez, R.L.3    Kuperman, D.A.4
  • 66
    • 0032530062 scopus 로고    scopus 로고
    • Enhanced anti-HIV-1 activity and altered chemotactic potency of NH2-terminally processed macrophage-derived chemokine (MDC) imply an additional MDC receptor
    • Struyf, S.; Proost, P.; Sozzani, S.; Mantovani, A.; Wuyts, A.; De Clercq, E.; Schols, D.; Van Damme, J. Enhanced anti-HIV-1 activity and altered chemotactic potency of NH2-terminally processed macrophage-derived chemokine (MDC) imply an additional MDC receptor. J. Immunol. 1998, 161, 2672-2675.
    • (1998) J. Immunol , vol.161 , pp. 2672-2675
    • Struyf, S.1    Proost, P.2    Sozzani, S.3    Mantovani, A.4    Wuyts, A.5    De Clercq, E.6    Schols, D.7    Van Damme, J.8
  • 68
    • 1542395857 scopus 로고    scopus 로고
    • CSF chemokine levels in relapsing neuromyelitis optica and multiple sclerosis
    • Narikawa, K.; Misu, T.; Fujihara, K.; Nakashima, I.; Sato, S.; Itoyama, Y. CSF chemokine levels in relapsing neuromyelitis optica and multiple sclerosis. J. Neuroimmunol. 2004, 149, 182-186.
    • (2004) J. Neuroimmunol , vol.149 , pp. 182-186
    • Narikawa, K.1    Misu, T.2    Fujihara, K.3    Nakashima, I.4    Sato, S.5    Itoyama, Y.6
  • 70
  • 71
    • 0033536062 scopus 로고    scopus 로고
    • CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions
    • Balashov, K.E.; Rottman, J.B.; Weiner, H.L.; Hancock, W.W. CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions. Proc. Natl. Acad. Sci. USA 1999, 96, 6873-6878.
    • (1999) Proc. Natl. Acad. Sci. USA , vol.96 , pp. 6873-6878
    • Balashov, K.E.1    Rottman, J.B.2    Weiner, H.L.3    Hancock, W.W.4
  • 72
    • 85006484066 scopus 로고    scopus 로고
    • An updated histological classification system for multiple sclerosis lesions
    • Kuhlmann, T.; Ludwin, S.; Prat, A.; Antel, J.; Bruck, W.; Lassmann, H. An updated histological classification system for multiple sclerosis lesions. Acta Neuropathol. 2017, 133, 13-24.
    • (2017) Acta Neuropathol , vol.133 , pp. 13-24
    • Kuhlmann, T.1    Ludwin, S.2    Prat, A.3    Antel, J.4    Bruck, W.5    Lassmann, H.6
  • 74
    • 84961390008 scopus 로고    scopus 로고
    • 1,25-Dihydroxyvitamin D3 Facilitates M2 Polarization and Upregulates TLR10 Expression on Human Microglial Cells
    • Verma, R.; Kim, J.Y. 1,25-Dihydroxyvitamin D3 Facilitates M2 Polarization and Upregulates TLR10 Expression on Human Microglial Cells. Neuroimmunomodulation 2016, 23, 75-80.
    • (2016) Neuroimmunomodulation , vol.23 , pp. 75-80
    • Verma, R.1    Kim, J.Y.2
  • 75
    • 0037334295 scopus 로고    scopus 로고
    • Regulation of chemokine receptor expression in human microglia and astrocytes
    • Flynn, G.; Maru, S.; Loughlin, J.; Romero, I.A.; Male, D. Regulation of chemokine receptor expression in human microglia and astrocytes. J. Neuroimmunol. 2003, 136, 84-93.
    • (2003) J. Neuroimmunol , vol.136 , pp. 84-93
    • Flynn, G.1    Maru, S.2    Loughlin, J.3    Romero, I.A.4    Male, D.5
  • 77
    • 84893372551 scopus 로고    scopus 로고
    • Disease-modifying therapy in multiple sclerosis and chronic inflammatory demyelinating polyradiculoneuropathy: Common and divergent current and future strategies
    • Melzer, N.; Meuth, S.G. Disease-modifying therapy in multiple sclerosis and chronic inflammatory demyelinating polyradiculoneuropathy: Common and divergent current and future strategies. Clin. Exp. Immunol. 2014, 175, 359-372.
    • (2014) Clin. Exp. Immunol , vol.175 , pp. 359-372
    • Melzer, N.1    Meuth, S.G.2
  • 79
    • 76449087805 scopus 로고    scopus 로고
    • Natalizumab treatment in multiple sclerosis: Marked decline of chemokines and cytokines in cerebrospinal fluid
    • Mellergard, J.; Edstrom, M.; Vrethem, M.; Ernerudh, J.; Dahle, C. Natalizumab treatment in multiple sclerosis: Marked decline of chemokines and cytokines in cerebrospinal fluid. Mult. Scler. 2010, 16, 208-217.
    • (2010) Mult. Scler , vol.16 , pp. 208-217
    • Mellergard, J.1    Edstrom, M.2    Vrethem, M.3    Ernerudh, J.4    Dahle, C.5
  • 80
    • 78650516882 scopus 로고    scopus 로고
    • Clinical study on CXCL13, CCL17, CCL20 and IL-17 as immune cell migration navigators in relapsing-remitting multiple sclerosis patients
    • Kalinowska-Lyszczarz, A.; Szczucinski, A.; Pawlak, M.A.; Losy, J. Clinical study on CXCL13, CCL17, CCL20 and IL-17 as immune cell migration navigators in relapsing-remitting multiple sclerosis patients. J. Neurol. Sci. 2011, 300, 81-85.
    • (2011) J. Neurol. Sci , vol.300 , pp. 81-85
    • Kalinowska-Lyszczarz, A.1    Szczucinski, A.2    Pawlak, M.A.3    Losy, J.4
  • 81
    • 84919712350 scopus 로고    scopus 로고
    • Current perspectives on interferon Beta-1b for the treatment of multiple sclerosis
    • Marziniak, M.; Meuth, S. Current perspectives on interferon Beta-1b for the treatment of multiple sclerosis. Adv. Ther. 2014, 31, 915-931.
    • (2014) Adv. Ther , vol.31 , pp. 915-931
    • Marziniak, M.1    Meuth, S.2
  • 82
    • 79959847463 scopus 로고    scopus 로고
    • Quantitative differences in the immunomodulatory effects of Rebif and Avonex in IFN-beta 1a treated multiple sclerosis patients
    • Christophi, G.P.; Christophi, J.A.; Gruber, R.C.; Mihai, C.; Mejico, L.J.; Massa, P.T.; Jubelt, B. Quantitative differences in the immunomodulatory effects of Rebif and Avonex in IFN-beta 1a treated multiple sclerosis patients. J. Neurol. Sci. 2011, 307, 41-45.
    • (2011) J. Neurol. Sci , vol.307 , pp. 41-45
    • Christophi, G.P.1    Christophi, J.A.2    Gruber, R.C.3    Mihai, C.4    Mejico, L.J.5    Massa, P.T.6    Jubelt, B.7
  • 83
    • 0035283409 scopus 로고    scopus 로고
    • Chemokine receptor expression on T cells in blood and cerebrospinal fluid at relapse and remission of multiple sclerosis: Imbalance of Th1/Th2-associated chemokine signaling
    • Misu, T.; Onodera, H.; Fujihara, K.; Matsushima, K.; Yoshie, O.; Okita, N.; Takase, S.; Itoyama, Y. Chemokine receptor expression on T cells in blood and cerebrospinal fluid at relapse and remission of multiple sclerosis: Imbalance of Th1/Th2-associated chemokine signaling. J. Neuroimmunol. 2001, 114, 207-212.
    • (2001) J. Neuroimmunol , vol.114 , pp. 207-212
    • Misu, T.1    Onodera, H.2    Fujihara, K.3    Matsushima, K.4    Yoshie, O.5    Okita, N.6    Takase, S.7    Itoyama, Y.8
  • 84
    • 9244249879 scopus 로고    scopus 로고
    • Expression of TH1/TH2-related chemokine receptors on peripheral T cells and correlation with clinical disease activity in patients with multiple sclerosis
    • Nakajima, H.; Fukuda, K.; Doi, Y.; Sugino, M.; Kimura, F.; Hanafusa, T.; Ikemoto, T.; Shimizu, A. Expression of TH1/TH2-related chemokine receptors on peripheral T cells and correlation with clinical disease activity in patients with multiple sclerosis. Eur. Neurol. 2004, 52, 162-168.
    • (2004) Eur. Neurol , vol.52 , pp. 162-168
    • Nakajima, H.1    Fukuda, K.2    Doi, Y.3    Sugino, M.4    Kimura, F.5    Hanafusa, T.6    Ikemoto, T.7    Shimizu, A.8
  • 85
    • 1242264279 scopus 로고    scopus 로고
    • Immunomonitoring measures in relapsing-remitting multiple sclerosis
    • Matsui, M.; Araya, S.I.; Wang, H.Y.; Matsushima, K.; Saida, T. Immunomonitoring measures in relapsing-remitting multiple sclerosis. J. Neuroimmunol. 2004, 148, 192-199.
    • (2004) J. Neuroimmunol , vol.148 , pp. 192-199
    • Matsui, M.1    Araya, S.I.2    Wang, H.Y.3    Matsushima, K.4    Saida, T.5
  • 86
    • 33745868391 scopus 로고    scopus 로고
    • Dynamic T-lymphocyte chemokine receptor expression induced by interferon-beta therapy in multiple sclerosis
    • Krakauer, M.; Sorensen, P.S.; Khademi, M.; Olsson, T.; Sellebjerg, F. Dynamic T-lymphocyte chemokine receptor expression induced by interferon-beta therapy in multiple sclerosis. Scand. J. Immunol. 2006, 64, 155-163.
    • (2006) Scand. J. Immunol , vol.64 , pp. 155-163
    • Krakauer, M.1    Sorensen, P.S.2    Khademi, M.3    Olsson, T.4    Sellebjerg, F.5
  • 87
    • 0347993165 scopus 로고    scopus 로고
    • Cyclophosphamide modulates CD4+ T cells into a T helper type 2 phenotype and reverses increased IFN-gamma production of CD8+ T cells in secondary progressive multiple sclerosis
    • Karni, A.; Balashov, K.; Hancock, W.W.; Bharanidharan, P.; Abraham, M.; Khoury, S.J.; Weiner, H.L. Cyclophosphamide modulates CD4+ T cells into a T helper type 2 phenotype and reverses increased IFN-gamma production of CD8+ T cells in secondary progressive multiple sclerosis. J. Neuroimmunol. 2004, 146, 189-198.
    • (2004) J. Neuroimmunol , vol.146 , pp. 189-198
    • Karni, A.1    Balashov, K.2    Hancock, W.W.3    Bharanidharan, P.4    Abraham, M.5    Khoury, S.J.6    Weiner, H.L.7
  • 88
    • 0242523144 scopus 로고    scopus 로고
    • Immune parameters associated with early treatment effects of high-dose intravenous methylprednisolone in multiple sclerosis
    • Wang, H.Y.; Matsui, M.; Araya, S.; Onai, N.; Matsushima, K.; Saida, T. Immune parameters associated with early treatment effects of high-dose intravenous methylprednisolone in multiple sclerosis. J. Neurol. Sci. 2003, 216, 61-66.
    • (2003) J. Neurol. Sci , vol.216 , pp. 61-66
    • Wang, H.Y.1    Matsui, M.2    Araya, S.3    Onai, N.4    Matsushima, K.5    Saida, T.6
  • 89
    • 78651252492 scopus 로고    scopus 로고
    • Expression and functional activity of chemokine receptors in glatiramer acetate-specific T cells isolated from multiple sclerosis patient receiving the drug glatiramer acetate
    • Hoglund, R.A.; Hestvik, A.L.; Holmoy, T.; Maghazachi, A.A. Expression and functional activity of chemokine receptors in glatiramer acetate-specific T cells isolated from multiple sclerosis patient receiving the drug glatiramer acetate. Hum. Immunol. 2011, 72, 124-134.
    • (2011) Hum. Immunol , vol.72 , pp. 124-134
    • Hoglund, R.A.1    Hestvik, A.L.2    Holmoy, T.3    Maghazachi, A.A.4
  • 90
    • 0035889488 scopus 로고    scopus 로고
    • Selective CC chemokine receptor expression by central nervous system-infiltrating encephalitogenic T cells during experimental autoimmune encephalomyelitis
    • Fife, B.T.; Paniagua, M.C.; Lukacs, N.W.; Kunkel, S.L.; Karpus, W.J. Selective CC chemokine receptor expression by central nervous system-infiltrating encephalitogenic T cells during experimental autoimmune encephalomyelitis. J. Neurosci. Res. 2001, 66, 705-714.
    • (2001) J. Neurosci. Res , vol.66 , pp. 705-714
    • Fife, B.T.1    Paniagua, M.C.2    Lukacs, N.W.3    Kunkel, S.L.4    Karpus, W.J.5
  • 93
    • 0034176818 scopus 로고    scopus 로고
    • Reduced chemokine and chemokine receptor expression in spinal cords of TCR BV8S2 transgenic mice protected against experimental autoimmune encephalomyelitis with BV8S2 protein
    • Matejuk, A.; Vandenbark, A.A.; Burrows, G.G.; Bebo, B.F.; Offner, H., Jr. Reduced chemokine and chemokine receptor expression in spinal cords of TCR BV8S2 transgenic mice protected against experimental autoimmune encephalomyelitis with BV8S2 protein. J. Immunol. 2000, 164, 3924-3931.
    • (2000) J. Immunol , vol.164 , pp. 3924-3931
    • Matejuk, A.1    Vandenbark, A.A.2    Burrows, G.G.3    Bebo, B.F.4    Offner, H.5
  • 94
    • 0034597050 scopus 로고    scopus 로고
    • Modulation of experimental autoimmune encephalomyelitis: Effect of altered peptide ligand on chemokine and chemokine receptor expression
    • Fischer, F.R.; Santambrogio, L.; Luo, Y.; Berman, M.A.; Hancock, W.W.; Dorf, M.E. Modulation of experimental autoimmune encephalomyelitis: Effect of altered peptide ligand on chemokine and chemokine receptor expression. J. Neuroimmunol. 2000, 110, 195-208.
    • (2000) J. Neuroimmunol , vol.110 , pp. 195-208
    • Fischer, F.R.1    Santambrogio, L.2    Luo, Y.3    Berman, M.A.4    Hancock, W.W.5    Dorf, M.E.6
  • 95
    • 84924311105 scopus 로고    scopus 로고
    • Immune modulation by a tolerogenic myelin oligodendrocyte glycoprotein (MOG)10-60 containing fusion protein in the marmoset experimental autoimmune encephalomyelitis model
    • Kap, Y.S.; van Driel, N.; Arends, R.; Rouwendal, G.; Verolin, M.; Blezer, E.; Lycke, N.; ‘t Hart, B.A. Immune modulation by a tolerogenic myelin oligodendrocyte glycoprotein (MOG)10-60 containing fusion protein in the marmoset experimental autoimmune encephalomyelitis model. Clin. Exp. Immunol. 2015, 180, 28-39.
    • (2015) Clin. Exp. Immunol , vol.180 , pp. 28-39
    • Kap, Y.S.1    Van Driel, N.2    Arends, R.3    Rouwendal, G.4    Verolin, M.5    Blezer, E.6    Lycke, N.7    ‘t Hart, B.A.8
  • 96
    • 84920084997 scopus 로고    scopus 로고
    • IFN-beta inhibits T cells accumulation in the central nervous system by reducing the expression and activity of chemokines in experimental autoimmune encephalomyelitis
    • Cheng, W.; Zhao, Q.; Xi, Y.; Li, C.; Xu, Y.; Wang, L.; Niu, X.; Wang, Z.; Chen, G. IFN-beta inhibits T cells accumulation in the central nervous system by reducing the expression and activity of chemokines in experimental autoimmune encephalomyelitis. Mol. Immunol. 2015, 64, 152-162.
    • (2015) Mol. Immunol , vol.64 , pp. 152-162
    • Cheng, W.1    Zhao, Q.2    Xi, Y.3    Li, C.4    Xu, Y.5    Wang, L.6    Niu, X.7    Wang, Z.8    Chen, G.9
  • 98
    • 79960195666 scopus 로고    scopus 로고
    • CCR4 contributes to the pathogenesis of experimental autoimmune encephalomyelitis by regulating inflammatory macrophage function
    • Forde, E.A.; Dogan, R.N.; Karpus, W.J. CCR4 contributes to the pathogenesis of experimental autoimmune encephalomyelitis by regulating inflammatory macrophage function. J. Neuroimmunol. 2011, 236, 17-26.
    • (2011) J. Neuroimmunol , vol.236 , pp. 17-26
    • Forde, E.A.1    Dogan, R.N.2    Karpus, W.J.3
  • 99
    • 84875804013 scopus 로고    scopus 로고
    • The importance of CCR4 and CCR6 in experimental autoimmune encephalomyelitis
    • Moriguchi, K.; Miyamoto, K.; Tanaka, N.; Yoshie, O.; Kusunoki, S. The importance of CCR4 and CCR6 in experimental autoimmune encephalomyelitis. J. Neuroimmunol. 2013, 257, 53-58.
    • (2013) J. Neuroimmunol , vol.257 , pp. 53-58
    • Moriguchi, K.1    Miyamoto, K.2    Tanaka, N.3    Yoshie, O.4    Kusunoki, S.5
  • 100
    • 85021438019 scopus 로고    scopus 로고
    • Chemokine CCL17 is expressed by dendritic cells in the CNS during experimental autoimmune encephalomyelitis and promotes pathogenesis of disease
    • Ruland, C.; Renken, H.; Kuzmanov, I.; Fattahi Mehr, A.; Schwarte, K.; Cerina, M.; Herrmann, A.; Otte, D.M.; Zimmer, A.; Schwab, N.; et al. Chemokine CCL17 is expressed by dendritic cells in the CNS during experimental autoimmune encephalomyelitis and promotes pathogenesis of disease. Brain Behav. Immun. 2017, 66, 382-393.
    • (2017) Brain Behav. Immun , vol.66 , pp. 382-393
    • Ruland, C.1    Renken, H.2    Kuzmanov, I.3    Fattahi Mehr, A.4    Schwarte, K.5    Cerina, M.6    Herrmann, A.7    Otte, D.M.8    Zimmer, A.9    Schwab, N.10
  • 101
    • 79251580358 scopus 로고    scopus 로고
    • CCL22 regulates experimental autoimmune encephalomyelitis by controlling inflammatory macrophage accumulation and effector function
    • Dogan, R.N.; Long, N.; Forde, E.; Dennis, K.; Kohm, A.P.; Miller, S.D.; Karpus, W.J. CCL22 regulates experimental autoimmune encephalomyelitis by controlling inflammatory macrophage accumulation and effector function. J. Leukoc. Biol. 2011, 89, 93-104.
    • (2011) J. Leukoc. Biol , vol.89 , pp. 93-104
    • Dogan, R.N.1    Long, N.2    Forde, E.3    Dennis, K.4    Kohm, A.P.5    Miller, S.D.6    Karpus, W.J.7
  • 102
    • 84899065548 scopus 로고    scopus 로고
    • Recent progress in the development of antagonists to the chemokine receptors CCR3 and CCR4
    • Pease, J.E.; Horuk, R. Recent progress in the development of antagonists to the chemokine receptors CCR3 and CCR4. Expert Opin. Drug Discov. 2014, 9, 467-483.
    • (2014) Expert Opin. Drug Discov , vol.9 , pp. 467-483
    • Pease, J.E.1    Horuk, R.2
  • 103
    • 84942363815 scopus 로고    scopus 로고
    • Targeting chemokine receptors in disease-A case study of CCR4
    • Solari, R.; Pease, J.E. Targeting chemokine receptors in disease-A case study of CCR4. Eur. J. Pharmacol. 2015, 763, 169-177.
    • (2015) Eur. J. Pharmacol , vol.763 , pp. 169-177
    • Solari, R.1    Pease, J.E.2
  • 104
    • 1642554783 scopus 로고    scopus 로고
    • Dominance of CCL22 over CCL17 in induction of chemokine receptor CCR4 desensitization and internalization on human Th2 cells
    • Mariani, M.; Lang, R.; Binda, E.; Panina-Bordignon, P.; D’Ambrosio, D. Dominance of CCL22 over CCL17 in induction of chemokine receptor CCR4 desensitization and internalization on human Th2 cells. Eur. J. Immunol. 2004, 34, 231-240.
    • (2004) Eur. J. Immunol , vol.34 , pp. 231-240
    • Mariani, M.1    Lang, R.2    Binda, E.3    Panina-Bordignon, P.4    D’Ambrosio, D.5
  • 105
    • 84880582202 scopus 로고    scopus 로고
    • Safety, tolerability, pharmacokinetics and pharmacodynamics of GSK2239633, a CC-chemokine receptor 4 antagonist, in healthy male subjects: Results from an open-label and from a randomised study
    • Cahn, A.; Hodgson, S.; Wilson, R.; Robertson, J.; Watson, J.; Beerahee, M.; Hughes, S.C.; Young, G.; Graves, R.; Hall, D.; et al. Safety, tolerability, pharmacokinetics and pharmacodynamics of GSK2239633, a CC-chemokine receptor 4 antagonist, in healthy male subjects: Results from an open-label and from a randomised study. BMC Pharmacol. Toxicol. 2013, 14, 14.
    • (2013) BMC Pharmacol. Toxicol , vol.14 , pp. 14
    • Cahn, A.1    Hodgson, S.2    Wilson, R.3    Robertson, J.4    Watson, J.5    Beerahee, M.6    Hughes, S.C.7    Young, G.8    Graves, R.9    Hall, D.10
  • 106
    • 33746609254 scopus 로고    scopus 로고
    • Antagonists of CCR4 as immunomodulatory agents
    • Purandare, A.V.; Somerville, J.E. Antagonists of CCR4 as immunomodulatory agents. Curr. Top. Med. Chem. 2006, 6, 1335-1344.
    • (2006) Curr. Top. Med. Chem , vol.6 , pp. 1335-1344
    • Purandare, A.V.1    Somerville, J.E.2
  • 108
    • 40849124250 scopus 로고    scopus 로고
    • An intracellular allosteric site for a specific class of antagonists of the CC chemokine G protein-coupled receptors CCR4 and CCR5
    • Andrews, G.; Jones, C.; Wreggett, K.A. An intracellular allosteric site for a specific class of antagonists of the CC chemokine G protein-coupled receptors CCR4 and CCR5. Mol. Pharmacol. 2008, 73, 855-867.
    • (2008) Mol. Pharmacol , vol.73 , pp. 855-867
    • Andrews, G.1    Jones, C.2    Wreggett, K.A.3
  • 110
    • 85029667710 scopus 로고    scopus 로고
    • Opportunities for therapeutic antibodies directed at G-protein-coupled receptors
    • Hutchings, C.J.; Koglin, M.; Olson, W.C.; Marshall, F.H. Opportunities for therapeutic antibodies directed at G-protein-coupled receptors. Nat. Rev. Drug Discov. 2017, 16, 787-810.
    • (2017) Nat. Rev. Drug Discov , vol.16 , pp. 787-810
    • Hutchings, C.J.1    Koglin, M.2    Olson, W.C.3    Marshall, F.H.4
  • 111
    • 85000625399 scopus 로고    scopus 로고
    • Mogamulizumab for the treatment of cutaneous T-cell lymphoma: Recent advances and clinical potential
    • Duvic, M.; Evans, M.; Wang, C. Mogamulizumab for the treatment of cutaneous T-cell lymphoma: Recent advances and clinical potential. Ther. Adv. Hematol. 2016, 7, 171-174.
    • (2016) Ther. Adv. Hematol , vol.7 , pp. 171-174
    • Duvic, M.1    Evans, M.2    Wang, C.3
  • 113
    • 85028912573 scopus 로고    scopus 로고
    • Mogamulizumab for the treatment of relapsed or refractory adult T-cell leukemia-lymphoma
    • Winsett, F.T.; Lewis, D.J.; Duvic, M. Mogamulizumab for the treatment of relapsed or refractory adult T-cell leukemia-lymphoma. Expert Rev. Hematol. 2017, 10, 757-760.
    • (2017) Expert Rev. Hematol , vol.10 , pp. 757-760
    • Winsett, F.T.1    Lewis, D.J.2    Duvic, M.3
  • 115
    • 84959358996 scopus 로고    scopus 로고
    • C-C chemokine receptor type 4 antagonist Compound 22 ameliorates experimental autoimmune encephalomyelitis
    • Moriguchi, K.; Miyamoto, K.; Tanaka, N.; Ueno, R.; Nakayama, T.; Yoshie, O.; Kusunoki, S. C-C chemokine receptor type 4 antagonist Compound 22 ameliorates experimental autoimmune encephalomyelitis. J. Neuroimmunol. 2016, 291, 54-58.
    • (2016) J. Neuroimmunol , vol.291 , pp. 54-58
    • Moriguchi, K.1    Miyamoto, K.2    Tanaka, N.3    Ueno, R.4    Nakayama, T.5    Yoshie, O.6    Kusunoki, S.7
  • 116
    • 84866277908 scopus 로고    scopus 로고
    • Effect of CC chemokine receptor 4 antagonism on the evolution of experimental autoimmune encephalomyelitis
    • author reply E2414
    • Othy, S.; Topcu, S.; Kaveri, S.V.; Bayry, J. Effect of CC chemokine receptor 4 antagonism on the evolution of experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. USA 2012, 109, E2412-E2413, author reply E2414.
    • (2012) Proc. Natl. Acad. Sci. USA , vol.109 , pp. E2412-E2413
    • Othy, S.1    Topcu, S.2    Kaveri, S.V.3    Bayry, J.4
  • 117
    • 33846303121 scopus 로고    scopus 로고
    • Effect of synthetic matrix metalloproteinase inhibitors on lipopolysaccharide-induced blood-brain barrier opening in rodents: Differences in response based on strains and solvents
    • Rosenberg, G.A.; Estrada, E.Y.; Mobashery, S. Effect of synthetic matrix metalloproteinase inhibitors on lipopolysaccharide-induced blood-brain barrier opening in rodents: Differences in response based on strains and solvents. Brain Res. 2007, 1133, 186-192.
    • (2007) Brain Res , vol.1133 , pp. 186-192
    • Rosenberg, G.A.1    Estrada, E.Y.2    Mobashery, S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.